Aquestive Therapeutics, Inc. Q2 Revenue USD 13.819 Million Vs. IBES Estimate USD 11.4 Million

AQST•2026-08-11

Q2 revenue and earnings figures

Aug. 11 (Reuters) - Aquestive Therapeutics, Inc. reported second-quarter revenue of $13.819 million versus the IBES estimate of $11.4 million.

Q2 net income: -$22.864 million
Q2 pretax profit: -$22.864 million
Q2 income from operations: -$8.223 million
Q2 adjusted EBITDA: -$5.2 million

Aquestive Therapeutics, Inc. Q2 Revenue USD 13.819 Million Vs. IBES Estimate USD 11.4 Million

Q2 revenue and earnings figures

Related News

Essential Utilities President-Aqua Colleen Arnold lepas 2.855 saham senilai $112.915,25

Abony Acquisition membukukan laba bersih FY26 kuartal II sebesar USD 1,84 juta; pendapatan bunga akun trust USD 2,04 juta

Vivos Therapeutics kantongi paten AS baru untuk teknologi perangkat oral Vivos CARE

Super Micro forecasts upbeat annual revenue on AI boom

Siebert Financial Q2 revenue more than doubles on growth in stock loan, investment banking units